Journal of Translational Medicine (Aug 2024)

Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism

  • Lijie Han,
  • Xianlei Sun,
  • Jingjing Kong,
  • Jin Li,
  • Kai Feng,
  • Yanliang Bai,
  • Xianjing Wang,
  • Zhenhua Zhu,
  • Fengyuan Yang,
  • Qingzhou Chen,
  • Mengmeng Zhang,
  • Baohong Yue,
  • Xiaoqian Wang,
  • Liyan Fu,
  • Yaoyao Chen,
  • Qiankun Yang,
  • Shuya Wang,
  • Qingxuan Xin,
  • Nannan Sun,
  • Danfeng Zhang,
  • Yiwei Zhou,
  • Yanxia Gao,
  • Junwei Zhao,
  • Yong Jiang,
  • Rongqun Guo

DOI
https://doi.org/10.1186/s12967-024-05577-x
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 24

Abstract

Read online

Abstract Acute graft-versus-host disease (aGVHD) is primarily driven by allogeneic donor T cells associated with an altered composition of the host gut microbiome and its metabolites. The severity of aGVHD after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is not solely determined by the host and donor characteristics; however, the underlying mechanisms remain unclear. Using single-cell RNA sequencing, we decoded the immune cell atlas of 12 patients who underwent allo-HSCT: six with aGVHD and six with non-aGVHD. We performed a fecal microbiota (16SrRNA sequencing) analysis to investigate the fecal bacterial composition of 82 patients: 30 with aGVHD and 52 with non-aGVHD. Fecal samples from these patients were analyzed for bile acid metabolism. Through multi-omic analysis, we identified a feedback loop involving “immune cell-gut microbes-bile acid metabolites” contributing to heightened immune responses in patients with aGVHD. The dysbiosis of the gut microbiota and disruption of bile acid metabolism contributed to an exaggerated interleukin-1 mediated immune response. Our findings suggest that resistin and defensins are crucial in mitigating against aGVHD. Therefore, a comprehensive multi-omic atlas incorporating immune cells, gut microbes, and bile acid metabolites was developed in this study and used to propose novel, non-immunosuppressive approaches to prevent aGVHD. Graphical abstract